Adagrasib: First Approval
Year: 2023
Type: review
Source: Drugs
Author: Sohita Dhillon
Institution: Springer Nature (New Zealand)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4319826818
